Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Cream

LATITUDE Pharmaceuticals Initiates Two More Collaboration Studies For Its PG Depot
LATITUDE Pharmaceuticals, Inc. (LPI), a San Diego-based drug formulation developer, announced today that it has initiated two new collaboration programs for its Phospholipid Gel (PG) Depot drug delivery platform. The programs are designed to provide prolonged and peak-free pharmacokinetic profiles for 3 and 7 days following a subcutaneous injection for an antibiotic and a protein drug, respectively. The new studies bring the total to seven feasibility/license agreements that are applying the PG Depot to deliver small molecules, peptides, and proteins for pain, metabolic disease, anti-bacterial, and cardiovascular applications.
generic viagra online
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
Boston Scientific Corporation (NYSE: BSX) announced it has received approval from the U.S. Food and Drug Administration (FDA) to market its TAXUS(R) Liberte(R) Atom(TM) Paclitaxel-Eluting Coronary Stent System, a highly deliverable, next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels. It was approved for use in vessels as small as 2.25 mm in diameter and joins the TAXUS(R) Express(R) Atom(TM) Stent as the only drug-eluting stents approved for small vessel use in the U.S. The Company plans to begin a full U.S. launch of TAXUS Liberte Atom next month. Purchase zoloft to treat depression.
News of the day
Novel Handheld Device Detects Anthrax With Outstanding Accuracy And Reliability
Veritide Ltd., a developer of innovative biological identification and detection solutions, today reported that new independent data to be presented at the Biodetection Technologies 2009 conference confirm the exceptional accuracy of its Ceeker™ (pronounced "seeker") portable bacterial detection device in discriminating between anthrax spores and similar-looking hoax substances. The data show that in over two weeks of testing at the Midwest Research Institute in Florida, the company"s Ceeker scanner accurately identified 100% of the anthrax samples used and was correct in 95% of tests involving hoax substances. These test results are consistent with similar results produced last year by a New Zealand forensic testing agency, Environmental Science and Research (ESR).
Diagnostics

Obama Health Reform Proposals And Alliances Scrutinized

Various news outlets examined the state of the administration"s health reform push. Roll Call reports that the Administration"s alliances with major health organizations may not be as strong as previously thought. "An analysis of these groups" positions suggests few are completely on board and several may oppose the president in the end. Obama and his aides do not explicitly say health providers like hospitals and drugmakers back the president"s proposals. But it would take a careful reading of comments out of the White House to understand this." Members of the administration have said that doctors, nurses, hospitals, drug companies, AARP and other groups are supportive. "The White House has also carefully staged events with health care providers, reinforcing the impression that everyone is on the same team." But while groups including PhRMA have not opposed Obama-backed legislation, they have "declined to support it." Likewise, the American Hospital Association has not endorsed the Senate health committee plan or the House plan and has "made clear that it will only accept the right type of public insurance option" (Koffler, 7/27). Press secretary Robert Gibbs appeared on Fox News Sunday, where he said that the president will be monitoring congressional progress this week, and "if enough progress has been made by Friday "having lawmakers go home for their regularly scheduled August recess is probably a good thing,"" The Hill reports. He said that the president had set the deadline to "poke and prod Congress into moving." During his appearance, Gibbs "attempted to paint a positive picture of the congressional stalemate over healthcare reform. He said that there is already 80 percent agreement over how reform should proceed and the sticking point is the remaining 20 percent" (Tiron, 7/26). In his weekly Saturday address, President Obama said reform legislation would allow small businesses to "tap into more affordable insurance that is now only available to large companies," Politico reports. He "aimed to address a key constituency - millions of small business owners - at a time when their lobby in Washington is ratcheting up its criticism of the bill. The U.S. Chamber of Commerce sent a letter Friday to Congress signed by more than 1,000 businesses, state and local chambers, and national organizations opposing the House bill." In response, "The White House offered the flip side of the debate in a 20-page report Saturday detailing the ways in which small businesses would benefit," including access to lower-cost plans, a small business tax credit and an exemption from the employer mandate (Brown, 7/25). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009